MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Moleculin Biotech, Inc.

MBRX

#4768
Moleculin Biotech, Inc. - Common Stock
2.7 1 USD
+2.65%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.71
2.71
Year Range
1.79
3.16
Daily Change
+2.65%
Monthly Change
+29.05%
6 month change
-13.97%
Year Change
-13.97%
Previous Close
2.6 4
Open
2.7 1
Low
2.7 1
High
2.7 1
Volume
12
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. MBRX
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 14.46 M
  • Employee 17
  • Founded 2015
  • CEO N/A
  • Website www.moleculin.com
  • Headquarter Delaware, United States
  • FIGI BBG00B9T47L9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

News

Investing Investing
MBRX
2026.03.11
Moleculin Biotech releases CEO update on leukemia trial
Investing Investing
VZ CAT PG SHW BA
2026.02.19
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%
Investing Investing
MBRX
2026.02.19
Moleculin Biotech stock plunges after warrant exercise agreement
Investing Investing
MBRX
2026.02.19
Moleculin Biotech raises $8.3 million through warrant exercise
Investing Investing
MBRX
2026.02.18
Moleculin Biotech stock rises as AML drug trial shows promising results
Investing Investing
MBRX
2026.02.18
Moleculin reports promising early data in pivotal AML treatment trial
Investing Investing
MBRX
2026.02.17
Moleculin Biotech stock rises after securing key Japanese patent
Investing Investing
MBRX
2026.02.17
Moleculin receives patent allowance in Japan for Annamycin preparation method
Investing Investing
MBRX
2026.02.13
Moleculin launches CEO Corner to enhance investor communication
Investing Investing
MBRX
2026.02.05
Moleculin Biotech stockholders approve warrant issuance, reject name change
Investing Investing
MBRX
2026.01.13
Moleculin’s Annamycin shows no cardiotoxicity in cancer trials
Investing Investing
MBRX
2026.01.12
Moleculin expects first MIRACLE trial data readout in Q1 2026

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd